Browsing by Author "Velinovic, Milos (6507311576)"
Now showing 1 - 8 of 8
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settings
Publication Genetic and environmental dispositions for cardiovascular variability: A pilot study(2018) ;Karan, Radmila (47161180600) ;Cvjeticanin, Suzana (55924655300) ;Kovacevic-Kostic, Natasa (15728235800) ;Nikolic, Dejan (26023650800) ;Velinovic, Milos (6507311576) ;Milicevic, Vladimir (57205739324)Obrenovic-Kircanski, Biljana (18134195100)Background: The aim of our study was to evaluate the degree of genetic homozygosity in the group of patients with coronary artery disease (CAD), as well as to evaluate morphogenetic variability in CAD patients regarding the presence of investigated risk factors (RF) compared to a control sample of individuals. Additionally, we aimed to evaluate the distribution of ABO blood type frequencies between tested samples of individuals. Methods: This study analyzed individual phenotype and morphogenetic variability of 17 homozygously-recessive characteristics (HRC), by using HRC test in a sample of 148 individuals in CAD patients group and 156 individuals in the control group. The following RF were analyzed: hypertension, diabetes mellitus, hyperlipidemia, and smoking. Results: The mean value of HRC in CAD patients is significantly higher, while variability decreases compared to the control sample (CAD patients: 4.24 ± 1.59, control sample: 3.75 ± 1.69; VCAD-patients = 37.50%, VC = 45.07%). There is a significant difference in individual variations of 17 HRC between control sample and CAD patients (χ2 = 169.144; p < 0.01), which points out to different variability for tested genes. Mean values of HRC significantly differed in CAD patients in regard to the number of RF present. A blood type (OR = 1.75) is significant predictor for CAD, while O blood type (OR = 0.43) was significantly associated with controls. Conclusion: There is a higher degree of recessive homozygosity in CAD patients versus individuals in the control sample, and the presence of significant variations in the degree of recessive homozygosity as the number of tested RF increases. © 2018 by the authors. Licensee MDPI, Basel, Switzerland. - Some of the metrics are blocked by yourconsent settings
Publication Pregnancy-related aortic aneurysm and dissection in patients with Marfan's syndrome: Medical and surgical management during pregnancy and after delivery(2011) ;Vranes, Mile (6701667966) ;Velinovic, Milos (6507311576) ;Kovacevic-Kostic, Natasa (15728235800) ;Savic, Dragutin (56957841400) ;Nikolic, Dejan (26023650800)Karan, Radmila (47161180600)In the current article, 3 cases of aortic aneurysm and dissection in pregnant patients with Marfan's syndrome are reported. It is well known that pregnancy is a risk factor for the development of aortic aneurysm and dissection in women with Marfan's syndrome since it is shown that dissection can develop both before and after labor. Marfan patients with an aortic root diameter greater than 4 cm should undergo preconceptual counseling for surgical aortic repair before pregnancy. Pregnant Marfan patients with an aortic aneurysm should be closely and continuously evaluated by multidisciplinary specialists in order to prevent possible aortic dissection that could be fatal for both the mother and the fetus. - Some of the metrics are blocked by yourconsent settings
Publication Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single center experience(2020) ;Putnik, Svetozar (16550571800) ;Terzić, Dusko (57195538891) ;Nestorović, Emilija (56090978800) ;Karan, Radmila (47161180600) ;Dobri, Milan (57215822773) ;Andrijasević, Vuk (57209304591) ;Zlatkovic, Mina (57215815589) ;Kostić, Nataša Kovačević (57215815186) ;Velinovic, Milos (6507311576) ;Ivanisevic, Dragan (57215819463)Ristić, Miljko (57214043577)INTRODUCTION: While the survival rates for patients with end-stage heart failure have dramatically improved with newer generations of left ventricular assist devices, LVAD-specific infections are important cause of morbidity, mortality, and hospital readmissions in these patients. METHODS: We performed a retrospective analysis of all driveline infections in patients who had undergone LVAD implantation at a single cardiosurgical center. Between June 2013 and March 2017, 51 patients underwent implantation of LVAD. Among these, 12 received Heart Ware LVAD,34 Heart Mate II LVAD, and 5 Heart Mate III LVAD. The end goal for LVAD therapy was destination therapy in three patients and bridge-to-transplantation in 48 patients. RESULTS: One month, six months, and one-year survival rates were 90%, 85%, and 81%, respectively. Five patients developed driveline infections. Median time from LVAD implantation to driveline infections was 126 days. One of these patients underwent heart transplantation. Two patients were treated with antibiotics and surgical driveline repositioning with extensive debridement of the wound. Two patients with a chronic infection were treated conservatively with regular wound cleaning. CONCLUSION: Driveline infections remain a serious therapeutic challenge. With the development of surgical techniques and new devices, it is possible to reduce morbidity and increase survival rate in patients with implanted LVAD. © 2020, Edizioni Luigi Pozzi. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Pulmonary artery hypertension as a risk factor for long-term survival after heart transplantation(2021) ;Matkovic, Milos (57113361300) ;Milicevic, Vladimir (57205739324) ;Bilbija, Ilija (57113576000) ;Aleksic, Nemanja (57209310510) ;Cubrilo, Marko (57209307258) ;Nestorovic, Emilija (56090978800) ;Antic, Ana (57224966433) ;Zlatkovic, Mina (57215815589) ;Velinovic, Milos (6507311576)Putnik, Svetozar (16550571800)Background: Heart failure is the most frequent cause of pulmonary artery hypertension (PAH) and its severity may predict the development of heart failure (HF) and is known to be a prognostic factor of poor outcome after heart transplant (HTx). The aim of this study was to investigate the impact of preoperative PAH related to left-sided HF on long-term survival after HTx and to identify the hemodynamic parameters of PAH that predict survival after HTx. Methods: A prospective observational trial was performed, and it included 44 patients subjected to heart transplantation. Patients were divided into two groups: The first one with the preoperative diagnosis of PAH and the second one without the PAH diagnosed prior to the HTx. The two groups were compared for baseline characteristics, operative characteristics, survival, and hemodynamic parameters obtained by right heart catheterization. Survival was analyzed using Kaplan Meyer analysis, and Cox regression analysis was performed to determine independent predictors of survival. Results: The median follow-up time was 637.4 days (1-2028 days). The median survival within the group of patients with preoperative PAH was 1144 days (95% CI 662.884-1625.116) and 1918.920 days (95% CI 1594.577-2243.263) within the group of patients without PAH (P = .023), HR 0.279 (95% [CI]: 0.086-0.910; P = .034. The 30-day mortality in patients within PAH group was significantly higher, six versus two patients in the non PAH group (χ2 = 5.103, P < .05), while the long-term outcome after this period did not differ between the groups. Patients with preoperative PAH had significantly higher values of MPAP, PCWP, TPG and PVRI, while CO and CI did not differ between the two groups. Mean PVRI was 359.1 ± 97.3 dyn·s·cm-5 in the group with preoperative PAH and 232.2 ± 22.75 dyn·s·cm-5 in the group without PAH, P < .001. TPG values were 11.95 ± 5.08 mmHg in the PAH group while patients without PAH had mean values of 5.16 ± 1.97 mmHg, P < .001. Cox regression analysis was done for © 2021 Forum Multimedia Publishing LLC. All rights reserved. - Some of the metrics are blocked by yourconsent settings
Publication Role of risk factors in prediction of asymptomatic carotid artery stenosis in patients with coronary artery disease(2016) ;Obrenovic-Kircanski, Biljana (18134195100) ;Panic, Dragan (57189322957) ;Parapid, Biljana (6506582242) ;Karan, Radmila (47161180600) ;Kovacevic-Kostic, Natasa (15728235800) ;Skoric-Hinic, Ljiljana (57189326121) ;Nikolic, Dejan (26023650800) ;Vasic, Dragan (7003336138) ;Vranes, Mile (6701667966)Velinovic, Milos (6507311576)Aims: To determine the frequency of asymptomatic carotid artery stenosis in patients with coronary artery disease and to what degree the extent of coronary artery disease and presence of certain risk factors can be indicators of carotid artery stenosis in asymptomatic patients. Material and methods: Retrospective evaluation of consecutive patients that underwent coronary artery bypass grafting (CABG) during one year without symptoms or signs of carotid artery stenosis. The pre-operative Doppler ultrasonography in color and B-mode, using Siemens Accuson Antares machine, was used to determine the presence and the degree of carotid artery stenosis. Patients were divided according to the presence of significant (≥50%) carotid artery stenosis. The same doctor performed all examinations. Following variables were analysed: Age, gender, body mass index, hypertension, diabetes, smoking, cholesterol, triglycerides and echocardiographic variables obtained from transthoracic echocardiography - the presence of aortic wall sclerosis, aortic valve sclerosis and mitral valve calcification. Results: We have demonstrated that in 18/272 (7.1%) of patients referred to CABG with hemodynamically significant carotid artery stenosis had asymptomatic stenosis. The risk of presence of carotid artery stenosis was more significant in those older than 60 years (OR 2.58; 95% CI 0.98-6.77, p=0.047) and in patients with left main coronary artery stenosis (OR 8.92; 95% CI 3.2-24.83, p < 0.001). Other investigated variables had no significant influence (p > 0.05). Conclusion: The presence of asymptomatic carotid artery stenosis is strongly associated with the presence of left main coronary artery stenosis and with age older than 60 years. Noninvasive screening for carotid disease is reasonable in these subgroups of patients referred to CABG. - Some of the metrics are blocked by yourconsent settings
Publication Serum lactate as reliable biomarker of acute kidney injury in low-risk cardiac surgery patients(2019) ;Radovic, Mina (37075736200) ;Bojic, Suzana (55965837500) ;Kotur-Stevuljevic, Jelena (6506416348) ;Lezaic, Visnja (55904881900) ;Milicic, Biljana (6603829143) ;Velinovic, Milos (6507311576) ;Karan, Radmila (47161180600)Simic-Ogrizovic, Sanja (55923197400)Background Cardiac surgery-associated acute kidney injury (CSA-AKI) frequently occurs in patients assessed as low-risk for developing CSA-AKI. Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1) and lactate are promising biomarkers of CSA-AKI but have not yet been explored in low-risk patients. Aim To evaluate urinary NGAL (uNGAL), KIM-1 and lactate as biomarkers of CSA-AKI in patients with low-risk for developing CSA-AKI. Methods This prospective, observational study included 100 adult elective cardiac surgery patients assessed as low-risk for developing CSA-AKI. UNGAL, KIM-1 and lactate were measured preoperatively, at the end of cardiopulmonary bypass (CPB) and 3, 12, 24 and 48 h later. Results Fifteen patients developed CSA-AKI. Patients with CSA-AKI had significantly higher lactate but similar uNGAL and KIM-1 levels compared to patients without CSA-AKI. Unlike uNGAL and KIM-1, postoperative lactate was good biomarker of CSA-AKI with the highest odds ratio (OR) 2.7 [1.4-4.9] 24 h after CPB. Peak lactate concentration ≥ 4 mmol/L carried dramatically higher risk for developing CSA-AKI (OR 6.3 [1.9-20.5]). Conclusions Unlike uNGAL and KIM-1, postoperative lactate was significant independent predictor of CSA-AKI with the highest odds ratio 24 h after CPB. © 2019 Mina Radovic, Suzana Bojic, Jelena Kotur-Stevuljevic, Visnja Lezaic, Biljana Milicic, Milos Velinovic, Radmila Karan, Sanja Simic-Ogrizovic, published by sciendo. - Some of the metrics are blocked by yourconsent settings
Publication Serum lactate as reliable biomarker of acute kidney injury in low-risk cardiac surgery patients(2019) ;Radovic, Mina (37075736200) ;Bojic, Suzana (55965837500) ;Kotur-Stevuljevic, Jelena (6506416348) ;Lezaic, Visnja (55904881900) ;Milicic, Biljana (6603829143) ;Velinovic, Milos (6507311576) ;Karan, Radmila (47161180600)Simic-Ogrizovic, Sanja (55923197400)Background Cardiac surgery-associated acute kidney injury (CSA-AKI) frequently occurs in patients assessed as low-risk for developing CSA-AKI. Neutrophil Gelatinase-Associated Lipocalin (NGAL), Kidney Injury Molecule-1 (KIM-1) and lactate are promising biomarkers of CSA-AKI but have not yet been explored in low-risk patients. Aim To evaluate urinary NGAL (uNGAL), KIM-1 and lactate as biomarkers of CSA-AKI in patients with low-risk for developing CSA-AKI. Methods This prospective, observational study included 100 adult elective cardiac surgery patients assessed as low-risk for developing CSA-AKI. UNGAL, KIM-1 and lactate were measured preoperatively, at the end of cardiopulmonary bypass (CPB) and 3, 12, 24 and 48 h later. Results Fifteen patients developed CSA-AKI. Patients with CSA-AKI had significantly higher lactate but similar uNGAL and KIM-1 levels compared to patients without CSA-AKI. Unlike uNGAL and KIM-1, postoperative lactate was good biomarker of CSA-AKI with the highest odds ratio (OR) 2.7 [1.4-4.9] 24 h after CPB. Peak lactate concentration ≥ 4 mmol/L carried dramatically higher risk for developing CSA-AKI (OR 6.3 [1.9-20.5]). Conclusions Unlike uNGAL and KIM-1, postoperative lactate was significant independent predictor of CSA-AKI with the highest odds ratio 24 h after CPB. © 2019 Mina Radovic, Suzana Bojic, Jelena Kotur-Stevuljevic, Visnja Lezaic, Biljana Milicic, Milos Velinovic, Radmila Karan, Sanja Simic-Ogrizovic, published by sciendo. - Some of the metrics are blocked by yourconsent settings
Publication The gender impact on morphogenetic variability in coronary artery disease: A preliminary study(2018) ;Karan, Radmila (47161180600) ;Obrenovic-Kircanski, Biljana (18134195100) ;Cvjeticanin, Suzana (55924655300) ;Kovacevic-Kostic, Natasa (15728235800) ;Velinovic, Milos (6507311576) ;Milicevic, Vladimir (57205739324) ;Vranes-Stoimirov, Milica (57246716100)Nikolic, Dejan (26023650800)We analyzed morphogenetic variability and degree of genetic homozygosity in male and female individuals with coronary artery disease (CAD) versus unaffected controls. We have tested 235 CAD patients; 109 were diagnosed also with diabetes mellitus (DM) and 126 with hypertension (HTN). We additionally evaluated 152 healthy individuals without manifested CAD. For the evaluation of the degree of recessive homozygosity, we have performed the homozygously recessive characteristics (HRC) test and tested 19 HRCs. In controls, the frequency of HRC for males was 2.88 ± 1.89, while for females, it was 3.65 ± 1.60. In the CAD group, the frequency of HRC for males was 4.21 ± 1.47, while for females, it was 4.73 ± 1.60. There is significant difference in HRC frequencies between controls and CAD separately for males (p < 0.001) and females (p < 0.001). The same applies between controls and CAD with DM (males: p < 0.001 and females: p = 0.004), and controls and CAD with HTN (males: p < 0.001 and females: p < 0.001). There is no significant difference in HRC frequencies between the group of CAD with DM and the group of CAD with HTN (males: p = 0.952 and females: p = 0.529). Our findings point to the increased degree of recessive homozygosity and decreased variability in both genders of CAD patients versus controls, indicating the potential genetic predisposition for CAD. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
